The CHMP recommends conditional marketing authorization of REGN's linvoseltamab to treat adults with relapsed and refractory multiple myeloma.

THE LAWSUIT: A class action securities lawsuit was filed against Regeneron Pharmaceuticals, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud ...

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) stock has gone relatively unnoticed from major headlines in 2024 as GLP-1 makers like Novo Nordisk A/S (NYSE: NVO) and Eli Lilly & Co. (NYSE: LLY ...

TARRYTOWN, N.Y. - Regeneron (NASDAQ:REGN) Pharmaceuticals, Inc. (NASDAQ: REGN), a prominent player in the biotechnology sector with a market capitalization of $77.1 billion and annual revenue of $ ...

Ten of 11 children born profoundly deaf experienced some degree of hearing improvement after receiving an experimental gene therapy developed by Regeneron Pharmaceuticals. A few of the children can ...

A gene therapy from Regeneron Pharmaceuticals Inc. improved hearing in nearly all deaf children in a clinical trial, results that could allow the company to seek regulatory approval for the one ...

I usually work... between 28 and 34 hours in a week. On the days that I work, I normally start at 9am and finish at either 1.30pm or 4pm, depending on what I have planned later on in my personal life.

Regeneron Pharmaceuticals Inc., No. 23-2086, 2025 U.S. App. LEXIS 3667 (1st Cir. Feb. 18, 2025) held that an Anti-Kickback Statute (“AKS”) violation must be the “but-for” cause for ...

Mental health professionals no longer diagnose ADD. Instead, they diagnose one of three types of ADHD: inattentive, hyperactive-impulsive, or combined. Attention deficit hyperactivity disorder ...

Regeneron’s gene therapy DB-OTO has restored partial hearing in 10 of 12 children with profound otoferlin-related deafness, a genetic condition researchers say is a perfect match for gene therapy. The ...